Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Sep. 30, 2020
Current assets:    
Cash $ 2,266,639 $ 959,309
Inventory 1,093,765 967,993
Prepaid expenses and other current assets 307,341 215,673
Total current assets 3,667,745 2,142,975
Long-term assets:    
Property and equipment, net 5,240 4,552
Other assets 3,500 3,500
Total long-term assets 8,740 8,052
Total assets 3,676,485 2,151,027
Current liabilities:    
Accounts payable 408,083 342,050
Accrued expenses and other liabilities 319,464 248,968
Current portion of derivative liability 1,000,000  
Current portion of PPP Loan 0 37,442
Total current liabilities 1,727,547 628,460
Long-term liabilities:    
Long-term portion of PPP loan 0 138,858
Accrued interest 167,137 17,781
Derivative liability 1,207,475 2,316,419
Total long-term liabilities 2,974,612 3,023,058
Total liabilities 4,702,159 3,651,518
Commitments and contingencies (Note 13)
Stockholders' equity (deficit):    
Common stock, $0.001 par value, 800,000,000 shares authorized as of September 30, 2021 and 2020, 237,169,770 and 193,0447,766 shares issued as of September 30, 2021 and 2020, and 236,719,770 and 193,044,766 outstanding as of September 30, 2021 and 2020 236,720 193,045
Additional paid-in capital 48,534,525 41,862,901
Accumulated deficit (49,796,919) (43,556,437)
Total stockholders' deficit (1,025,674) (1,500,491)
Total liabilities and stockholders' deficit 3,676,485 2,151,027
Series 1 convertible notes    
Long-term liabilities:    
Convertible notes 550,000 $ 550,000
Series 2 convertible notes    
Long-term liabilities:    
Convertible notes $ 1,050,000